Alterity Short Term Debt vs Net Tangible Assets Analysis
ATHE Stock | USD 1.87 0.01 0.53% |
Alterity Therapeutics financial indicator trend analysis is way more than just evaluating Alterity Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alterity Therapeutics is a good investment. Please check the relationship between Alterity Therapeutics Short Term Debt and its Net Tangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alterity Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.
Short Term Debt vs Net Tangible Assets
Short Term Debt vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alterity Therapeutics Short Term Debt account and Net Tangible Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Alterity Therapeutics' Short Term Debt and Net Tangible Assets is -0.17. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Alterity Therapeutics, assuming nothing else is changed. The correlation between historical values of Alterity Therapeutics' Short Term Debt and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Alterity Therapeutics are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Short Term Debt i.e., Alterity Therapeutics' Short Term Debt and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | -0.17 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Short Term Debt
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Alterity Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alterity Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alterity Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.At present, Alterity Therapeutics' Enterprise Value is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 54.2K | 102.3K | 92.0K | 87.4K | Research Development | 14.7M | 13.2M | 15.2M | 7.7M |
Alterity Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Alterity Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alterity Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 13.3M | 33.6M | 41.4M | 27.3M | 31.4M | 21.8M | |
Total Stockholder Equity | 10.5M | 30.5M | 35.5M | 22.8M | 26.2M | 19.3M | |
Net Debt | (9.2M) | (28.0M) | (34.7M) | (15.6M) | (14.0M) | (14.7M) | |
Cash | 9.2M | 28.1M | 34.8M | 15.8M | 18.1M | 15.8M | |
Cash And Short Term Investments | 9.2M | 28.1M | 34.8M | 15.8M | 18.1M | 15.8M | |
Common Stock Shares Outstanding | 1.5M | 2.8M | 2.4B | 2.4B | 2.8B | 2.9B | |
Liabilities And Stockholders Equity | 13.3M | 33.6M | 41.4M | 27.3M | 31.4M | 21.8M | |
Other Stockholder Equity | (4.3M) | (20.8M) | (22.0M) | 4.0M | 3.6M | 3.4M | |
Total Current Assets | 13.2M | 33.5M | 41.1M | 27.0M | 31.1M | 18.6M | |
Common Stock | 160.7M | 197.4M | 213.8M | 214.0M | 246.1M | 258.4M | |
Other Current Liab | 1.2M | 1.2M | (26.9K) | 2.6M | 2.9M | 3.1M | |
Total Current Liabilities | 2.7M | 3.1M | 5.8M | 4.4M | 5.0M | 2.7M | |
Property Plant And Equipment Net | 71.4K | 96.8K | 218.5K | 268.9K | 309.2K | 324.7K | |
Retained Earnings | (151.0M) | (169.7M) | (181.9M) | (195.1M) | (175.6M) | (166.8M) | |
Accounts Payable | 954.0K | 1.4M | 2.7M | 1.7M | 2.0M | 1.3M | |
Non Current Assets Total | 71.4K | 96.8K | 218.5K | 268.9K | 242.0K | 229.9K | |
Non Currrent Assets Other | (34.2K) | (49.3K) | (72.6K) | (150.9K) | (135.8K) | (129.0K) | |
Net Receivables | 3.5M | 4.3M | 4.7M | 8.7M | 10.0M | 10.5M | |
Inventory | 567.9K | 1.1M | 1.6M | 2.6M | 3.0M | 3.1M | |
Other Current Assets | 10.3K | 9.4K | 10.2K | 39.8K | 35.8K | 34.0K | |
Total Liab | 2.8M | 3.1M | 5.9M | 4.5M | 5.2M | 2.8M | |
Common Stock Total Equity | 143.9M | 156.6M | 160.7M | 197.4M | 227.1M | 128.1M | |
Non Current Liabilities Total | 42.4K | 47.7K | 73.6K | 122.7K | 110.4K | 69.6K | |
Property Plant And Equipment Gross | 71.4K | 96.8K | 733.1K | 728.8K | 838.1K | 880.0K | |
Accumulated Other Comprehensive Income | 866.1K | 2.8M | 3.6M | 4.0M | 4.6M | 4.8M | |
Short Long Term Debt Total | 33.7K | 65.6K | 117.5K | 210.4K | 189.3K | 132.0K | |
Short Term Debt | 32.9K | 27.7K | 57.6K | 107.2K | 96.5K | 107.5K | |
Other Assets | (0.53) | 0.03 | (0.48) | 1.0 | 0.9 | 0.86 | |
Other Liab | 41.5K | 9.8K | 13.8K | 19.5K | 22.4K | 15.0K | |
Net Tangible Assets | 7.2M | 30.5M | 35.5M | 22.8M | 26.2M | 24.6M | |
Capital Lease Obligations | 33.7K | 65.6K | 117.5K | 210.4K | 241.9K | 254.0K | |
Property Plant Equipment | 71.4K | 96.8K | 218.5K | 268.9K | 309.2K | 324.7K | |
Net Invested Capital | 7.2M | 30.5M | 35.5M | 22.8M | 26.2M | 23.9M | |
Net Working Capital | 7.1M | 30.4M | 35.3M | 22.7M | 26.1M | 23.8M | |
Capital Stock | 160.7M | 197.4M | 213.8M | 214.0M | 246.1M | 207.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alterity Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.Note that the Alterity Therapeutics information on this page should be used as a complementary analysis to other Alterity Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Alterity Stock analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Alterity Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alterity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 0.6 | Quarterly Revenue Growth (0.20) | Return On Assets (0.29) | Return On Equity (0.54) |
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.